Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07730736) titled 'Analysis of Clinical Characteristics of Chronic Hepatitis B Combined With MAFLD in Different TCM Syndrome Types' on July 22.

Study Type: Observational

Primary Sponsor: Foshan Hospital of Traditional Chinese Medicine

Condition: Chronic Hepatitis B Metabolic Associated Fatty Liver Disease

Recruitment Status: Not recruiting

Date of First Enrollment: March 5, 2025

Target Sample Size: 1000

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07730736

Disclaimer: Curated by HT Syndication....